Insights

Channel Partnerships DMC already leverages distribution and strategic collaborations with LBB Specialties and Toyobo, and participates in Danone’s Biotech Open Platform, signaling a scalable go-to-market model. Sales opportunity: engage additional distributors and co-development partners to expand North American and global reach and package sustainable fermentation ingredients.

Sustainability Demand The focus on decarbonizing chemicals and sustainable food ingredients aligns with rising demand from chemical manufacturers and consumer brands for lower-carbon processes. Sales angle: position DMC as a preferred supplier of carbon-efficient fermentation ingredients, supported by sustainability data and lifecycle assessments.

Platform Advantage Dynamic Metabolic Control offers predictable, robust fermentation that reduces technical risk and time-to-scale for partners. Sales angle: offer pilots, technology licensing, or joint development agreements to large manufacturers seeking improved yields and process reliability.

Growth Momentum With revenue in the low tens of millions, $39M in funding, and leadership additions in 2025, DMC signals growth readiness and strategic direction. Sales angle: pursue strategic partnerships, including co-investments or equity deals, and target mid-market industrial players seeking scalable biomanufacturing solutions.

Market Access Collaborations with Danone, Toyobo, and LBB indicate appetite for platform-based collaborations and supply-chain resilience. Sales angle: target global consumer brands and chemical producers for integrated sustainability programs and multi-region deployment.

Similar companies to DMC Biotechnologies, Inc.

DMC Biotechnologies, Inc. Tech Stack

DMC Biotechnologies, Inc. uses 8 technology products and services including Cloudflare DNS, TriNet, WP Engine, and more. Explore DMC Biotechnologies, Inc.'s tech stack below.

  • Cloudflare DNS
    Domain Name Services
  • TriNet
    Human Resource Management System
  • WP Engine
    Platform As A Service
  • Python
    Programming Languages
  • C
    Programming Languages
  • Google Search Console
    Web Analytics
  • Nginx
    Web Servers
  • prettyPhoto
    Web Tools And Plugins

Media & News

DMC Biotechnologies, Inc.'s Email Address Formats

DMC Biotechnologies, Inc. uses at least 1 format(s):
DMC Biotechnologies, Inc. Email FormatsExamplePercentage
First@dmcbio.comJohn@dmcbio.com
80%
Last.F@dmcbio.comDoe.J@dmcbio.com
10%
Last@dmcbio.comDoe@dmcbio.com
8%
LastF@dmcbio.comDoeJ@dmcbio.com
2%

Frequently Asked Questions

What is DMC Biotechnologies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
DMC Biotechnologies, Inc.'s official website is dmcbio.com and has social profiles on LinkedInCrunchbase.

What is DMC Biotechnologies, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
DMC Biotechnologies, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does DMC Biotechnologies, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, DMC Biotechnologies, Inc. has approximately 42 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer & Founder: M. L.Vice President Strategic Alliances: M. L.Laboratory Technician: A. L.. Explore DMC Biotechnologies, Inc.'s employee directory with LeadIQ.

What industry does DMC Biotechnologies, Inc. belong to?

Minus sign iconPlus sign icon
DMC Biotechnologies, Inc. operates in the Biotechnology Research industry.

What technology does DMC Biotechnologies, Inc. use?

Minus sign iconPlus sign icon
DMC Biotechnologies, Inc.'s tech stack includes Cloudflare DNSTriNetWP EnginePythonCGoogle Search ConsoleNginxprettyPhoto.

What is DMC Biotechnologies, Inc.'s email format?

Minus sign iconPlus sign icon
DMC Biotechnologies, Inc.'s email format typically follows the pattern of First@dmcbio.com. Find more DMC Biotechnologies, Inc. email formats with LeadIQ.

How much funding has DMC Biotechnologies, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, DMC Biotechnologies, Inc. has raised $53M in funding. The last funding round occurred on Dec 02, 2021 for $39M.

When was DMC Biotechnologies, Inc. founded?

Minus sign iconPlus sign icon
DMC Biotechnologies, Inc. was founded in 2014.
DMC Biotechnologies, Inc. logo

DMC Biotechnologies, Inc.

Biotechnology ResearchNorth Carolina, United States11-50 Employees

DMC Biotechnologies, Inc. is a U.S. biotechnology company focused on biomanufacturing that seeks to transform how chemicals are produced. Headquartered in Durham, North Carolina, it applies precision fermentation and synthetic biology to decarbonize chemical production and to generate sustainable, natural ingredients for foods and supplements, while aiming to bolster the security of global supply chains. Its Dynamic Metabolic Control platform is intended to streamline biology and support fermentation that is more predictable, robust, and efficient.

The company serves clients in chemical manufacturing and the food ingredients sector that seek sustainable production methods and reliable ingredient supply. Within the biotechnology research and biomanufacturing landscape, it pursues collaborations to bring its technology to market applications. In April 2026, DMC Biotechnologies announced a partnership with LBB Specialties to expand its distribution and technical capabilities.

Section iconCompany Overview

Website
dmcbio.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $53M

    DMC Biotechnologies, Inc. has raised a total of $53M of funding over 5 rounds. Their latest funding round was raised on Dec 02, 2021 in the amount of $39Mas a series_b.

  • $10M$25M

    DMC Biotechnologies, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $53M

    DMC Biotechnologies, Inc. has raised a total of $53M of funding over 5 rounds. Their latest funding round was raised on Dec 02, 2021 in the amount of $39Mas a series_b.

  • $10M$25M

    DMC Biotechnologies, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.